01Established products
Generic medicines, supply opportunities, dossiers and regional access needs.
Company
Pharmaceutical development shaped by need.
Tribal Pharmaceuticals works across established medicines and selected new therapeutic opportunities. We pursue a programme only when the evidence and practical route support it.
01
Company overview
One company, two development routes.
The need determines the route, not the other way around.
We develop medicines, not categories.
Some needs call for better access to an established medicine, a new strength, an improved formulation or a more reliable source of supply.
Others call for repurposing, reformulation, an in-licensed programme or a selected new candidate. Both routes require evidence, rights, regulation, quality, manufacture and sustainable supply to work together.
02
Scope
Opportunities we consider.
01
02Product improvements
New strengths, formulations, routes, combinations and presentations that address a defined limitation.
03Known compounds
Repurposing and indication questions with a credible rationale and available rights.
04Development assets
In-licensed, incomplete or selected new programmes with a definable next step.
03
Operating model
The operating model fits the programme.
Different medicines need different expertise, infrastructure, rights and regional knowledge.
Assessment brings scientific, clinical, regulatory, product, quality, manufacturing, rights and commercial perspectives together early.
Once selected, a programme follows the work its next decision requires. That may include evidence review, product development, clinical study, regulatory activity, technology transfer, licensing or regional commercialisation.
Clear responsibility
Work may be done directly or with qualified specialists. In either case, responsibilities, oversight and material decisions must remain explicit.
Continue exploring